109 related articles for article (PubMed ID: 1697947)
1. Relationship of the effective refractory period and monophasic action potential duration after a step increase in pacing frequency.
Morgan JM; Cunningham AD; Rowland E
Pacing Clin Electrophysiol; 1990 Aug; 13(8):1002-8. PubMed ID: 1697947
[TBL] [Abstract][Full Text] [Related]
2. Detection of rapid changes in ventricular refractoriness in human studies.
Toivonen L; Kettunen E; Simelius K; Parikka H
Pacing Clin Electrophysiol; 2002 Mar; 25(3):300-7. PubMed ID: 11990659
[TBL] [Abstract][Full Text] [Related]
3. The maximum effect of an increase in rate on human ventricular refractoriness.
Morady F; Kadish AH; Toivonen LK; Kushner JA; Schmaltz S
Pacing Clin Electrophysiol; 1988 Dec; 11(12):2223-34. PubMed ID: 2463610
[TBL] [Abstract][Full Text] [Related]
4. Change of atrial refractory period after short duration of rapid atrial pacing: regional differences and possible mechanisms.
Lee SH; Chen SA; Yu WC; Cheng JJ; Kaun P; Hung CR; Chang MS; Lin FY
Pacing Clin Electrophysiol; 1999 Jun; 22(6 Pt 1):927-34. PubMed ID: 10392391
[TBL] [Abstract][Full Text] [Related]
5. A new single catheter technique for simultaneous measurement of action potential duration and refractory period in vivo.
Franz MR; Chin MC; Sharkey HR; Griffin JC; Scheinman MM
J Am Coll Cardiol; 1990 Oct; 16(4):878-86. PubMed ID: 2212368
[TBL] [Abstract][Full Text] [Related]
6. Dispersion of monophasic action potential duration: demonstrable in humans after premature ventricular extrastimulation but not in steady state.
Morgan JM; Cunningham D; Rowland E
J Am Coll Cardiol; 1992 May; 19(6):1244-53. PubMed ID: 1373420
[TBL] [Abstract][Full Text] [Related]
7. Monophasic action potential duration during programmed electrical stimulation.
Kanaan N; Jenkins J; Childs K; Ge YZ; Kadish A
Pacing Clin Electrophysiol; 1991 Jun; 14(6):1049-59. PubMed ID: 1715066
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous recording of atrial and ventricular monophasic action potentials: monophasic action potential duration during atrial pacing, ventricular pacing, and ventricular fibrillation.
Stroobandt R; Brachmann J; Bourgeois I; Wielders P; Kübler W; Senges J
Pacing Clin Electrophysiol; 1985 Jul; 8(4):502-11. PubMed ID: 2410875
[TBL] [Abstract][Full Text] [Related]
9. Endocardial monophasic action potential recordings for the detection of myocardial ischemia in man: a study using atrial pacing stress and myocardial perfusion scintigraphy.
John RM; Taggart PI; Sutton PM; Costa DC; Ell PJ; Swanton H
Am Heart J; 1991 Dec; 122(6):1599-609. PubMed ID: 1957755
[TBL] [Abstract][Full Text] [Related]
10. Effects of the class III antiarrhythmic drug dofetilide on ventricular monophasic action potential duration and QT interval dispersion in stable angina pectoris.
Sedgwick ML; Rasmussen HS; Cobbe SM
Am J Cardiol; 1992 Dec; 70(18):1432-7. PubMed ID: 1442614
[TBL] [Abstract][Full Text] [Related]
11. Description of the strength-interval relation with external noninvasive pacing.
Luck JC; Grubb BP; Markel ML
Pacing Clin Electrophysiol; 1990 Dec; 13(12 Pt 2):2031-7. PubMed ID: 1704588
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous recording of monophasic action potentials and contractile force from the human heart.
Franz M; Schöttler M; Schaefer J; Seed WA
Klin Wochenschr; 1980 Dec; 58(24):1357-9. PubMed ID: 7206595
[TBL] [Abstract][Full Text] [Related]
13. Relations between monophasic action potential duration and refractoriness after cardioversion of persistent atrial fibrillation: results in wash-out and amiodarone-treated patients.
Pandozi C; Gentilucci G; Calò L; Castro A; Lamberti F; Loricchio ML; Santini L; Magris B; Bulava A; Peichl P; Santini M
Ital Heart J; 2003 Apr; 4(4):257-63. PubMed ID: 12784779
[TBL] [Abstract][Full Text] [Related]
14. Frequency-dependent effects of quinidine on the ventricular action potential and QRS duration in humans.
Nademanee K; Stevenson WG; Weiss JN; Frame VB; Antimisiaris MG; Suithichaiyakul T; Pruitt CM
Circulation; 1990 Mar; 81(3):790-6. PubMed ID: 2306831
[TBL] [Abstract][Full Text] [Related]
15. Dose-related shortening of ventricular tachycardia cycle length after administration of the KATP channel opener bimakalim in a 4-day-old chronic infarct anesthetized pig model.
Aidonidis I; Poyatzi A; Stamatiou G; Lymberi M; Stamatoyannis N; Molyvdas PA
J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):222-30. PubMed ID: 19587223
[TBL] [Abstract][Full Text] [Related]
16. Human ventricular refractoriness. Effects of cycle length, pacing site and atropine.
Guss SB; Kastor JA; Josephson ME; Schare DL
Circulation; 1976 Mar; 53(3):450-5. PubMed ID: 1248076
[TBL] [Abstract][Full Text] [Related]
17. Atrial refractoriness and action potential duration after sudden reversal of atrioventricular sequence.
Kettunen E; Parikka H; Verkkala K; Toivonen L
Pacing Clin Electrophysiol; 2004 Jan; 27(1):10-8. PubMed ID: 14720149
[TBL] [Abstract][Full Text] [Related]
18. The monophasic action potential: a simple in vivo model to evaluate the effects of antiarrhythmic drugs at atrial level.
Dobreanu D; Caraşca E; Cotoi S
Rom J Intern Med; 1998; 36(1-2):37-46. PubMed ID: 10660967
[TBL] [Abstract][Full Text] [Related]
19. Effects of propranolol on ventricular repolarization in man.
Endresen K; Amlie JP
Eur J Clin Pharmacol; 1990; 39(2):123-5. PubMed ID: 2253660
[TBL] [Abstract][Full Text] [Related]
20. Electrical and mechanical restitution of the human heart at different rates of stimulation.
Franz MR; Schaefer J; Schöttler M; Seed WA; Noble MI
Circ Res; 1983 Dec; 53(6):815-22. PubMed ID: 6640866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
